MedTrace Logo

Profermin® in Active Ulcerative Colitis

NCT01245465 · Status: COMPLETED · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 39

Last updated 2010-11-23

No results posted yet for this study

Summary

In this study the investigators aim was to investigate the safety and possible efficacy of Profermin® in patients with ulcerative colitis. The investigators also aimed at assessing the usefulness of a new online daily symptom registration system.

Conditions

Interventions

OTHER

Profermin

Medical Food (food for special medical purposes)

Sponsors & Collaborators

  • Hvidovre University Hospital

    collaborator OTHER

  • Nordisk Rebalance A/S

    lead INDUSTRY

Principal Investigators

  • Hans Israelsen, PhD · Nordisk Rebalance A/S

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-01-31
Primary Completion
2009-11-30
Completion
2009-11-30

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01245465 on ClinicalTrials.gov